Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.
about
Combined pulmonary fibrosis and emphysema syndrome: a reviewTherapeutic Approach to Adult Fibrotic Lung DiseasesManaging comorbidities in idiopathic pulmonary fibrosisCoaching patients during pulmonary function testing: A practical guideCombined pulmonary fibrosis and emphysema (CPFE): what radiologist should know.Combined pulmonary fibrosis and emphysema: an increasingly recognized condition.Idiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis.The value of CT for disease detection and prognosis determination in combined pulmonary fibrosis and emphysema (CPFE).Combined pulmonary fibrosis and emphysema.Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis.Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension--clinical management.Clinical relevance of plasma prostaglandin F2α metabolite concentrations in patients with idiopathic pulmonary fibrosis.Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemmaCombined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone.Prognosis of nonspecific interstitial pneumonia correlates with perivascular CD4+ T lymphocyte infiltration of the lung.Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis.Visually stratified CT honeycombing as a survival predictor in combined pulmonary fibrosis and emphysemaAdiponectin inhibits Wnt co-receptor, Lrp6, phosphorylation and β-catenin signaling.Diagnosis and management of interstitial lung disease.Managing Idiopathic Pulmonary Fibrosis: Which Drug for Which Patient?Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis.The Preoperative Composite Physiologic Index May Predict Mortality in Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema.Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications.Impact of combined pulmonary fibrosis and emphysema on surgical complications and long-term survival in patients undergoing surgery for non-small-cell lung cancerUnderstanding COPD-overlap syndromes.Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers.Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.Clinical efficacy and safety of ICS/LABA in patients with combined idiopathic pulmonary fibrosis and emphysemaPulmonary fibrosis and emphysema: Is the emphysema type associated with the pattern of fibrosis?Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease.Annual Change in Pulmonary Function and Clinical Characteristics of Combined Pulmonary Fibrosis and Emphysema and Idiopathic Pulmonary Fibrosis: Over a 3-Year Follow-up.Pulmonary hypertension and systemic sclerosis: the role of high-resolution computed tomography.Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone.Emphysema and pulmonary fibrosis: coincidence or conspiracy?Thin-section computed tomography-determined usual interstitial pneumonia pattern affects the decision-making process for resection in newly diagnosed lung cancer patients: a retrospective study.Assessing the Therapeutic Response to Pirfenidone in Idiopathic Pulmonary Fibrosis: Can We Do Better than with Forced Vital Capacity Alone?Clinical characteristics and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema: a systematic review and meta-analysis of 13 studies.Extracellular matrix in lung development, homeostasis and disease.The prognostic impact of combined pulmonary fibrosis and emphysema in patients with clinical stage IA non-small cell lung cancer.
P2860
Q24614740-F35B80B6-E2FB-4CEC-B25C-99E7FFA21D5CQ26741569-89E000C1-84B0-466A-86FA-5EC1D1564BFEQ26785617-8A49387B-BA61-47C3-8572-63AE4A2A3BACQ26797422-0D0C3C3F-859A-457E-B788-590CE53FF69FQ30251899-9868F894-13F3-4B50-BA4E-6386B769CA03Q33942950-2CD9AB93-75B7-4AA5-97A3-9B0EFE535C57Q34026607-A706FA32-56BF-484D-A505-04B8CF44D06FQ34156210-E14BE9B6-8E79-4264-ABCA-6FE4027BA478Q34325239-A6406BB2-A2FC-4D88-B727-29F817DD2169Q34480454-485BDC88-4CFF-4D86-9019-F9C55C0F1010Q34756421-EC374E4D-4882-4583-B88D-A9FBB0216E98Q34776159-F0C39B8D-5E56-4B36-9647-8CCDBC927BBAQ35029858-EF61F70D-C0C2-4A21-9AE5-965ACC9B7B63Q35568385-B4E334AD-819B-44EE-8DFE-D7778AD08A28Q35819353-A2DE780D-19F0-48FE-BBDB-89B9E9DADF6DQ36060275-ED8C130B-16C1-4EED-AB21-F6AD0A3B3109Q36181634-F1D1B827-41C2-4797-ADC3-1A1C95C053FAQ36550608-E68D36D9-D6D8-49CE-AE66-3E61BEE89DC0Q36563098-3937FD70-4FB5-4F6C-A062-2E806BAE950BQ38288028-00D79A2C-50F5-41A6-8BFA-696A23746538Q38598382-0A916E81-7528-48D4-8015-27592ED0A1E5Q38705047-AC91654D-ECCD-4C25-A141-670FEB0F25F9Q38715439-86F891F0-3D35-4BFC-B3E7-87421E3550C7Q38812037-80C2AF9F-A122-4878-91BC-F7901ED20130Q38880363-33523E2F-E731-4513-9FD5-A3AC11140E98Q39173255-25B53B65-9080-4FB1-898A-43B54C7EB223Q39456087-5AA2FB69-7774-4BE6-ADE9-A3FC80CBF615Q40234409-940745CB-A127-4119-88F3-BB0B9E8F4805Q41450264-E3D65A40-6F1F-4C11-B167-999FE099E430Q41784217-227EE65D-927C-4CC3-A492-7BEE58BE1484Q42050224-A01BC81B-0479-4474-8BB9-93DA6F598336Q42247408-91D2BE28-D060-4C3A-836E-8204D3F1B614Q43754038-0AF696DF-BEDD-400F-BF1E-C1DA77B7951DQ46209938-F377BBD0-666C-485C-A87F-2B3349D3563BQ46658703-AC8C6AD6-19E7-4164-AFE8-003CD283523EQ47204595-07E3114E-8CAF-438B-8C53-9BF1A17324DCQ48218867-60EDA267-1F59-4468-9545-73F250991089Q49200880-E30678BC-A6AD-440C-B4B8-7A44E2BE58A3Q50420061-A7EAC116-A905-4C40-850A-92144E306929Q51804751-C763BA0A-2A5A-4067-83FC-42CFD68DFBA8
P2860
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pulmonary function measures pr ...... monary fibrosis and emphysema.
@ast
Pulmonary function measures pr ...... monary fibrosis and emphysema.
@en
type
label
Pulmonary function measures pr ...... monary fibrosis and emphysema.
@ast
Pulmonary function measures pr ...... monary fibrosis and emphysema.
@en
prefLabel
Pulmonary function measures pr ...... monary fibrosis and emphysema.
@ast
Pulmonary function measures pr ...... monary fibrosis and emphysema.
@en
P2093
P2860
P1476
Pulmonary function measures pr ...... monary fibrosis and emphysema.
@en
P2093
A Lagstein
A M Nambiar
A R Chughtai
B Sundaram
E A Kazerooni
F J Martinez
K R Flaherty
P2860
P304
P356
10.1183/09031936.00114010
P577
2010-12-09T00:00:00Z